Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Simplifying changes requires clear steps and reminders. Learn practical ways to make mid-month edits that stick and save you time.
23,956 articlesInvestors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
During a broad AI stock drawdown, Cathie Wood doubling down on CoreWeave signals a high-conviction bet. This article ...
Sen. JD Vance faulted the Trump administration's handling of Epstein-related documents, calling out missteps in commu...
Alphabet reports results after the bell, but the line that matters most might be capex. This guide shows how data-cen...
New GDP figures show fourth-quarter growth remained positive but cooled, challenging the notion of a looming slowdown...
RAD Intel hits Nasdaq with the ticker $RADI after raising more than $50 million, marking a 4,900% valuation jump in f...
Geopolitical strain near Iran is intensifying, with potential ripple effects on oil prices and household budgets. Ana...
Markets in March 2026 are volatile, pushing traders to seek reliable borrow access and fast execution. This article i...
The AI hype is undeniable, but investors want answers: is this a bubble about burst just or the start of a longer asc...
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...
Investing $1,000 can kickstart a disciplined, growth-oriented portfolio. Learn a four-stock plan using proven names a...
A major AWS chip deal cements NVIDIA's role in cloud AI, even as AWS pursues its own chip path. This helps scale AI w...